fluorouracil has been researched along with 4-hydroxycyclophosphamide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, N; Gasparetto, C; Gillio, A; Moore, MA; Muench, MO; O'Reilly, RJ; Smith, C | 1 |
| Averette, HE; Gerhardt, RT; Guerra, L; Perras, JP; Petru, E; Ramos, R; Sevin, BU | 1 |
| Bergh, J; Fjällskog, ML; Freijs, A; Karlsson, MO; Larsson, R; Nygren, P; Sandström, M | 1 |
| Bornstein, R; Fruehauf, JP; Li, KT; McLaren, CE; Mehta, RS; Nguyen, KP; Parker, RJ; Yu, IR | 1 |
| Amant, F; Beijnen, J; Chai, DC; De Catte, L; de Hoon, J; Devlieger, R; Heyns, L; Van Bree, R; Van Calsteren, K; Verbesselt, R | 1 |
| Afsar, NA; Ahmad, HR; Ahmed, KZ; Cascorbi, I; Haenisch, S; Mateen, A; Remmler, C; Ufer, M; Usman, A | 1 |
1 trial(s) available for fluorouracil and 4-hydroxycyclophosphamide
| Article | Year |
|---|---|
Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients.
Topics: Adult; Aged; Aldehyde Dehydrogenase; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytochrome P-450 Enzyme System; Doxorubicin; Female; Fluorouracil; Genotype; Glutathione Transferase; Humans; Leukocyte Count; Middle Aged | 2012 |
5 other study(ies) available for fluorouracil and 4-hydroxycyclophosphamide
| Article | Year |
|---|---|
Purification and partial characterization of a human hematopoietic precursor population.
Topics: Animals; Antigens, CD34; Antigens, Differentiation; Bone Marrow; Bone Marrow Cells; Cell Division; Cell Separation; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Cyclophosphamide; Fluorouracil; Granulocytes; Hematopoietic Stem Cells; Humans; Interleukin-3; Macaca; Macrophages; Male; Phenotype; Recombinant Proteins | 1991 |
Characterization of in vitro chemosensitivity of perioperative human ovarian malignancies by adenosine triphosphate chemosensitivity assay.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; In Vitro Techniques; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1991 |
Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Half-Life; Humans; Middle Aged | 1996 |
Breast cancer survival and in vitro tumor response in the extreme drug resistance assay.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Assay; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Predictive Value of Tests; Survival Analysis | 2001 |
Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model.
Topics: Amniotic Fluid; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromatography, High Pressure Liquid; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Female; Fetal Blood; Fluorouracil; Mass Spectrometry; Papio; Placenta; Pregnancy; Pregnancy, Animal; Vinblastine | 2010 |